Status:
RECRUITING
Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction
Lead Sponsor:
Asfendiyarov Kazakh National Medical University
Conditions:
Cardiovascular Diseases (CVD)
Type 2 Diabetes
Eligibility:
All Genders
18-69 years
Brief Summary
This study aims to enhance personalized and preventive care for non-communicable diseases (NCDs) in Kazakhstan by examining epigenetic factors, predicting biological age and reproductive function usin...
Eligibility Criteria
Inclusion
- Adults aged 18 to 69 years.
- Residents of 17 regions of Kazakhstan.
- Willingness to participate and provide informed consent.
Exclusion
- Age less than 18 years old or over 69 years old.
- Failure to provide informed consent or incomplete participation in data collection procedures.
Key Trial Info
Start Date :
March 3 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
6720 Patients enrolled
Trial Details
Trial ID
NCT06953180
Start Date
March 3 2025
End Date
December 31 2026
Last Update
July 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asfendiyarov Kazakh National Medical University
Almaty, Kazakhstan, Kazakhstan, 050000